{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:22:30Z","timestamp":1793424150543,"version":"4.5.0"},"reference-count":189,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02614-x","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T08:52:20Z","timestamp":1738918340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Ferroptosis: mechanism and role in diabetes-related cardiovascular diseases"],"prefix":"10.1186","volume":"24","author":[{"given":"Ziyi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefei","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"issue":"4","key":"2614_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/XCE.0000000000000210","volume":"9","author":"AH Heald","year":"2020","unstructured":"Heald AH, Stedman M, Davies M, Livingston M, Alshames R, Lunt M, Rayman G, Gadsby R. Estimating life years lost to diabetes: outcomes from analysis of National Diabetes Audit and Office of National Statistics data. Cardiovasc Endocrinol Metabolism. 2020;9(4):183\u20135.","journal-title":"Cardiovasc Endocrinol Metabolism"},{"key":"2614_CR2","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"39","key":"2614_CR3","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx N, Federici M, Schutt K, Muller-Wieland D, Ajjan RA, Antunes MJ, Christodorescu RM, Crawford C, Di Angelantonio E, Eliasson B, et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043\u2013140.","journal-title":"Eur Heart J"},{"key":"2614_CR4","doi-asserted-by":"publisher","first-page":"154838","DOI":"10.1016\/j.metabol.2021.154838","volume":"123","author":"JS Yun","year":"2021","unstructured":"Yun JS, Ko SH. Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes. Metab Clin Exp. 2021;123:154838.","journal-title":"Metab Clin Exp"},{"issue":"9","key":"2614_CR5","doi-asserted-by":"publisher","first-page":"e722","DOI":"10.1161\/CIR.0000000000001040","volume":"145","author":"JJ Joseph","year":"2022","unstructured":"Joseph JJ, Deedwania P, Acharya T, Aguilar D, Bhatt DL, Chyun DA, Di Palo KE, Golden SH, Sperling LS. Comprehensive Management of Cardiovascular Risk factors for adults with type 2 diabetes: a Scientific Statement from the American Heart Association. Circulation. 2022;145(9):e722\u201359.","journal-title":"Circulation"},{"key":"2614_CR6","doi-asserted-by":"publisher","first-page":"m2297","DOI":"10.1136\/bmj.m2297","volume":"370","author":"X Cai","year":"2020","unstructured":"Cai X, Zhang Y, Li M, Wu JH, Mai L, Li J, Yang Y, Hu Y, Huang Y. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020;370:m2297.","journal-title":"BMJ"},{"key":"2614_CR7","doi-asserted-by":"crossref","unstructured":"Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ 2016.","DOI":"10.1136\/bmj.i5953"},{"issue":"11","key":"2614_CR8","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","volume":"126","author":"RH Ritchie","year":"2020","unstructured":"Ritchie RH, Abel ED. Basic mechanisms of Diabetic Heart Disease. Circ Res. 2020;126(11):1501\u201325.","journal-title":"Circ Res"},{"issue":"3","key":"2614_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jacc.2017.11.019","volume":"71","author":"TH Marwick","year":"2018","unstructured":"Marwick TH, Ritchie R, Shaw JE, Kaye D. Implications of underlying mechanisms for the Recognition and Management of Diabetic Cardiomyopathy. J Am Coll Cardiol. 2018;71(3):339\u201351.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2614_CR10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"14","key":"2614_CR11","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185(14):2401\u201321.","journal-title":"Cell"},{"issue":"2","key":"2614_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gasc\u00f3n S, Hatzios SK, Kagan VE, et al. Ferroptosis: a regulated cell death Nexus linking metabolism, Redox Biology, and Disease. Cell. 2017;171(2):273\u201385.","journal-title":"Cell"},{"issue":"3","key":"2614_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, Kang R, Tang D. Ferroptosis: process and function. Cell Death Differ. 2016;23(3):369\u201379.","journal-title":"Cell Death Differ"},{"issue":"6","key":"2614_CR14","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25(6):424\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2614_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev-immunol-042617-053010","volume":"36","author":"S Nagata","year":"2018","unstructured":"Nagata S. Apoptosis and clearance of apoptotic cells. Annu Rev Immunol. 2018;36:489\u2013517.","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"2614_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Reviews Clin Oncol. 2020;17(7):395\u2013417.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"3","key":"2614_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, et al. Molecular mechanisms of cell death: recommendations of the nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25(3):486\u2013541.","journal-title":"Cell Death Differ"},{"issue":"5","key":"2614_CR18","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021;18(5):1106\u201321.","journal-title":"Cell Mol Immunol"},{"key":"2614_CR19","doi-asserted-by":"publisher","first-page":"107717","DOI":"10.1016\/j.pharmthera.2020.107717","volume":"220","author":"I Khan","year":"2021","unstructured":"Khan I, Yousif A, Chesnokov M, Hong L, Chefetz I. A decade of cell death studies: breathing new life into necroptosis. Pharmacol Ther. 2021;220:107717.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"2614_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/15548627.2023.2259732","volume":"20","author":"Z Lin","year":"2024","unstructured":"Lin Z, Long F, Kang R, Klionsky DJ, Yang M, Tang D. The lipid basis of cell death and autophagy. Autophagy. 2024;20(3):469\u201388.","journal-title":"Autophagy"},{"issue":"6","key":"2614_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","volume":"19","author":"I Dikic","year":"2018","unstructured":"Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018;19(6):349\u201364.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2614_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-024-01958-2","volume":"9","author":"Y Liu","year":"2024","unstructured":"Liu Y, Pan R, Ouyang Y, Gu W, Xiao T, Yang H, Tang L, Wang H, Xiang B, Chen P. Pyroptosis in health and disease: mechanisms, regulation and clinical perspective. Signal Transduct Target Therapy. 2024;9(1):245.","journal-title":"Signal Transduct Target Therapy"},{"key":"2614_CR23","doi-asserted-by":"crossref","unstructured":"Li S-Y, Zhao N, Wei D, Pu N, Hao X-N, Huang J-M, Peng G-H, Tao Y. Ferroptosis in the ageing retina: a malevolent fire of diabetic retinopathy. Ageing Res Rev 2024, 93.","DOI":"10.1016\/j.arr.2023.102142"},{"issue":"1","key":"2614_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X Fang","year":"2023","unstructured":"Fang X, Ardehali H, Min J, Wang F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol. 2023;20(1):7\u201323.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"2614_CR25","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","volume":"99","author":"DP Del Re","year":"2019","unstructured":"Del Re DP, Amgalan D, Linkermann A, Liu Q, Kitsis RN. Fundamental mechanisms of regulated cell death and implications for Heart Disease. Physiol Rev. 2019;99(4):1765\u2013817.","journal-title":"Physiol Rev"},{"issue":"Pt 1","key":"2614_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.freeradbiomed.2023.09.034","volume":"209","author":"Q Huang","year":"2023","unstructured":"Huang Q, Tian H, Tian L, Zhao X, Li L, Zhang Y, Qiu Z, Lei S, Xia Z. Inhibiting rev-erbalpha-mediated ferroptosis alleviates susceptibility to myocardial ischemia-reperfusion injury in type 2 diabetes. Free Radic Biol Med. 2023;209(Pt 1):135\u201350.","journal-title":"Free Radic Biol Med"},{"key":"2614_CR27","doi-asserted-by":"publisher","first-page":"119935","DOI":"10.1016\/j.lfs.2021.119935","volume":"284","author":"Z Meng","year":"2021","unstructured":"Meng Z, Liang H, Zhao J, Gao J, Liu C, Ma X, Liu J, Liang B, Jiao X, Cao J, et al. HMOX1 upregulation promotes ferroptosis in diabetic atherosclerosis. Life Sci. 2021;284:119935.","journal-title":"Life Sci"},{"key":"2614_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.freeradbiomed.2024.08.021","volume":"224","author":"Z Xiao","year":"2024","unstructured":"Xiao Z, Yang H, Pan Y, Meng H, Qu Z, Kong B, Shuai W, Huang H. Ubiquitin-specific protease 38 promotes atrial fibrillation in diabetic mice by stabilizing iron regulatory protein 2. Free Radic Biol Med. 2024;224:88\u2013102.","journal-title":"Free Radic Biol Med"},{"key":"2614_CR29","doi-asserted-by":"publisher","first-page":"113595","DOI":"10.1016\/j.biopha.2022.113595","volume":"154","author":"Q Huang","year":"2022","unstructured":"Huang Q, Tian L, Zhao X, Lei S, Zhao B, Qiu Z, Xia ZY. Rev-erbs agonist SR9009 alleviates ischemia-reperfusion injury by heightening endogenous cardioprotection at onset of type-2 diabetes in rats: down-regulating ferritinophagy\/ferroptosis signaling. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie. 2022;154:113595.","journal-title":"Biomed Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"2614_CR30","doi-asserted-by":"publisher","first-page":"114795","DOI":"10.1016\/j.biopha.2023.114795","volume":"163","author":"Q Huang","year":"2023","unstructured":"Huang Q, Tian L, Zhang Y, Qiu Z, Lei S, Xia ZY. Nobiletin alleviates myocardial ischemia-reperfusion injury via ferroptosis in rats with type-2 diabetes mellitus. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie. 2023;163:114795.","journal-title":"Biomed Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"2614_CR31","doi-asserted-by":"crossref","unstructured":"Tang Y-j, Zhang Z, Yan T, Chen K, Xu G-f, Xiong S-q, Wu D-q, Chen J, Jose PA, Zeng C-. y: Irisin attenuates type 1 diabetic cardiomyopathy by anti-ferroptosis via SIRT1-mediated deacetylation of p53. Cardiovasc Diabetol 2024, 23(1).","DOI":"10.1186\/s12933-024-02183-5"},{"issue":"4","key":"2614_CR32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"2614_CR33","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.7150\/thno.54113","volume":"11","author":"X Wu","year":"2021","unstructured":"Wu X, Li Y, Zhang S, Zhou X. Ferroptosis as a novel therapeutic target for cardiovascular disease. Theranostics. 2021;11(7):3052\u20139.","journal-title":"Theranostics"},{"key":"2614_CR34","doi-asserted-by":"crossref","unstructured":"Koleini N, Shapiro JS, Geier J, Ardehali H. Ironing out mechanisms of iron homeostasis and disorders of iron deficiency. J Clin Invest 2021, 131(11).","DOI":"10.1172\/JCI148671"},{"key":"2614_CR35","doi-asserted-by":"crossref","unstructured":"Liu P, Zhang Z, Cai Y, Li Z, Zhou Q, Chen Q. Ferroptosis: mechanisms and role in diabetes mellitus and its complications. Ageing Res Rev 2024, 94.","DOI":"10.1016\/j.arr.2024.102201"},{"key":"2614_CR36","doi-asserted-by":"crossref","unstructured":"Li J, Cao F, Yin H-l, Huang Z-j, Lin Z-t, Mao N, Sun B, Wang G. Ferroptosis: past, present and future. Cell Death Dis 2020, 11(2).","DOI":"10.1038\/s41419-020-2298-2"},{"issue":"9","key":"2614_CR37","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/nm920","volume":"9","author":"GY Oudit","year":"2003","unstructured":"Oudit GY, Sun H, Trivieri MG, Koch SE, Dawood F, Ackerley C, Yazdanpanah M, Wilson GJ, Schwartz A, Liu PP, et al. L-type Ca2\u2009+\u2009channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med. 2003;9(9):1187\u201394.","journal-title":"Nat Med"},{"issue":"5","key":"2614_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00109-005-0029-x","volume":"84","author":"GY Oudit","year":"2006","unstructured":"Oudit GY, Trivieri MG, Khaper N, Liu PP, Backx PH. Role of L-type Ca2\u2009+\u2009channels in iron transport and iron-overload cardiomyopathy. J Mol Med. 2006;84(5):349\u201364.","journal-title":"J Mol Med"},{"key":"2614_CR39","doi-asserted-by":"crossref","unstructured":"Ravingerova T, Kindernay L, Bartekova M, Ferko M, Adameova A, Zohdi V, Bernatova I, Ferenczyova K, Lazou A. The Molecular mechanisms of Iron Metabolism and its role in Cardiac Dysfunction and Cardioprotection. Int J Mol Sci 2020, 21(21).","DOI":"10.3390\/ijms21217889"},{"issue":"4","key":"2614_CR40","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","volume":"127","author":"X Fang","year":"2020","unstructured":"Fang X, Cai Z, Wang H, Han D, Cheng Q, Zhang P, Gao F, Yu Y, Song Z, Wu Q, et al. Loss of Cardiac Ferritin H facilitates Cardiomyopathy via Slc7a11-Mediated ferroptosis. Circ Res. 2020;127(4):486\u2013501.","journal-title":"Circ Res"},{"issue":"1","key":"2614_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","volume":"142","author":"MW Hentze","year":"2010","unstructured":"Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to Tango: regulation of mammalian Iron metabolism. Cell. 2010;142(1):24\u201338.","journal-title":"Cell"},{"issue":"6","key":"2614_CR42","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1089\/ars.2020.8175","volume":"35","author":"B Hassannia","year":"2021","unstructured":"Hassannia B, Van Coillie S, Vanden Berghe T. Ferroptosis: Biological rust of lipid membranes. Antioxid Redox Signal. 2021;35(6):487\u2013509.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"2614_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13(1):91\u20138.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"2614_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M de la Rojo","year":"2018","unstructured":"de la Rojo M, Chapman E, Zhang DD. NRF2 and the hallmarks of Cancer. Cancer Cell. 2018;34(1):21\u201343.","journal-title":"Cancer Cell"},{"issue":"8","key":"2614_CR45","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599\u2013620.","journal-title":"Protein Cell"},{"issue":"7","key":"2614_CR46","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/cdd.2016.25","volume":"23","author":"L Magtanong","year":"2016","unstructured":"Magtanong L, Ko PJ, Dixon SJ. Emerging roles for lipids in non-apoptotic cell death. Cell Death Differ. 2016;23(7):1099\u2013109.","journal-title":"Cell Death Differ"},{"issue":"6","key":"2614_CR47","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1182\/blood.V84.6.1697.1697","volume":"84","author":"C Finch","year":"1994","unstructured":"Finch C. Regulators of iron balance in humans. Blood. 1994;84(6):1697\u2013702.","journal-title":"Blood"},{"issue":"7","key":"2614_CR48","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang X, Wang H, Han D, Xie E, Yang X, Wei J, Gu S, Gao F, Zhu N, Yin X, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci USA. 2019;116(7):2672\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2614_CR49","doi-asserted-by":"publisher","first-page":"e324321","DOI":"10.1016\/j.crad.2017.10.012","volume":"73","author":"B Wang","year":"2018","unstructured":"Wang B, Zhang Y, Sun N, Gu S, Ding F, Xu S, Zhou H, Liu Y. MRI-measured myocardial iron load in patients with severe diabetic heart failure. Clin Radiol. 2018;73(3):e324321\u20137.","journal-title":"Clin Radiol"},{"issue":"23","key":"2614_CR50","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","volume":"22","author":"L Anderson","year":"2001","unstructured":"Anderson L. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22(23):2171\u20139.","journal-title":"Eur Heart J"},{"issue":"14","key":"2614_CR51","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.110.007641","volume":"123","author":"JP Carpenter","year":"2011","unstructured":"Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, de Noronha SV, Sheppard MN, Porter JB, Walker JM, Wood JC, et al. On T2* magnetic resonance and cardiac iron. Circulation. 2011;123(14):1519\u201328.","journal-title":"Circulation"},{"issue":"1","key":"2614_CR52","doi-asserted-by":"publisher","first-page":"100996","DOI":"10.1016\/j.jocmr.2024.100996","volume":"26","author":"I Lechner","year":"2024","unstructured":"Lechner I, Reindl M, Oberhollenzer F, Tiller C, Holzknecht M, Fink P, Kremser T, Bonatti P, Troger F, Henninger B, et al. Association of dysglycaemia with persistent infarct core iron in patients with acute ST-segment elevation myocardial infarction. J Cardiovasc Magn Resonance: Official J Soc Cardiovasc Magn Reson. 2024;26(1):100996.","journal-title":"J Cardiovasc Magn Resonance: Official J Soc Cardiovasc Magn Reson"},{"issue":"3","key":"2614_CR53","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2337\/diabetes.51.3.813","volume":"51","author":"A Nitenberg","year":"2002","unstructured":"Nitenberg A, Ledoux S, Valensi P, Sachs R, Antony I. Coronary microvascular adaptation to myocardial metabolic demand can be restored by inhibition of iron-catalyzed formation of oxygen free radicals in type 2 diabetic patients. Diabetes. 2002;51(3):813\u20138.","journal-title":"Diabetes"},{"issue":"7","key":"2614_CR54","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00210-013-0863-2","volume":"386","author":"HL Shan","year":"2013","unstructured":"Shan HL, Wang Y, Wu JW, Hang PZ, Li X, Sun LH, Qi JC, Mao YY, Sun ZD, Du ZM. Verapamil reverses cardiac iron overload in streptozocin-induced diabetic rats. Naunyn Schmiedebergs Arch Pharmacol. 2013;386(7):645\u201350.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"2614_CR55","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1159\/000315077","volume":"25","author":"N Zhao","year":"2010","unstructured":"Zhao N, Sun Z, Mao Y, Hang P, Jiang X, Sun L, Zhao J, Du Z. Myocardial iron metabolism in the regulation of cardiovascular diseases in rats. Cell Physiol Biochemistry: Int J Experimental Cell Physiol Biochem Pharmacol. 2010;25(6):587\u201394.","journal-title":"Cell Physiol Biochemistry: Int J Experimental Cell Physiol Biochem Pharmacol"},{"issue":"12","key":"2614_CR56","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.2337\/db19-1176","volume":"69","author":"H Zang","year":"2020","unstructured":"Zang H, Wu W, Qi L, Tan W, Nagarkatti P, Nagarkatti M, Wang X, Cui T. Autophagy inhibition enables Nrf2 to exaggerate the Progression of Diabetic Cardiomyopathy in mice. Diabetes. 2020;69(12):2720\u201334.","journal-title":"Diabetes"},{"issue":"2","key":"2614_CR57","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10534-014-9717-8","volume":"27","author":"AF Sampaio","year":"2014","unstructured":"Sampaio AF, Silva M, Dornas WC, Costa DC, Silva ME, Dos Santos RC, de Lima WG, Pedrosa ML. Iron toxicity mediated by oxidative stress enhances tissue damage in an animal model of diabetes. Biometals: Int J role Metal ions Biology Biochem Med. 2014;27(2):349\u201361.","journal-title":"Biometals: Int J role Metal ions Biology Biochem Med"},{"issue":"5","key":"2614_CR58","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s12012-024-09852-7","volume":"24","author":"D Zhou","year":"2024","unstructured":"Zhou D, Yang Y, Chen J, Zhou J, He J, Liu D, Zhang A, Yuan B, Jiang Y, Xia W, et al. N-acetylcysteine protects against myocardial ischemia-reperfusion Injury through anti-ferroptosis in type 1 Diabetic mice. Cardiovasc Toxicol. 2024;24(5):481\u201398.","journal-title":"Cardiovasc Toxicol"},{"issue":"8","key":"2614_CR59","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.metabol.2010.11.003","volume":"60","author":"PA Rowe","year":"2011","unstructured":"Rowe PA, Kavanagh K, Zhang L, Harwood HJ Jr., Wagner JD. Short-term hyperglycemia increases arterial superoxide production and iron dysregulation in atherosclerotic monkeys. Metab Clin Exp. 2011;60(8):1070\u201380.","journal-title":"Metab Clin Exp"},{"issue":"5","key":"2614_CR60","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1039\/C4IB00025K","volume":"6","author":"E Pretorius","year":"2014","unstructured":"Pretorius E, Kell DB. Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases. Integr Biol. 2014;6(5):486\u2013510.","journal-title":"Integr Biol"},{"key":"2614_CR61","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.taap.2017.11.005","volume":"338","author":"S Chan","year":"2018","unstructured":"Chan S, Lian Q, Chen MP, Jiang D, Ho JTK, Cheung YF, Chan GC. Deferiprone inhibits iron overload-induced tissue factor bearing endothelial microparticle generation by inhibition oxidative stress induced mitochondrial injury, and apoptosis. Toxicol Appl Pharmcol. 2018;338:148\u201358.","journal-title":"Toxicol Appl Pharmcol"},{"issue":"14","key":"2614_CR62","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1096\/fj.05-4095fje","volume":"19","author":"C Tsch\u00f6pe","year":"2005","unstructured":"Tsch\u00f6pe C, Walther T, Escher F, Spillmann F, Du J, Altmann C, Schimke I, Bader M, Sanchez-Ferrer CF, Schultheiss HP, et al. Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2005;19(14):2057\u20139.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"issue":"8","key":"2614_CR63","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s00125-005-1821-4","volume":"48","author":"M Diamant","year":"2005","unstructured":"Diamant M, Lamb HJ, Smit JW, de Roos A, Heine RJ. Diabetic cardiomyopathy in uncomplicated type 2 diabetes is associated with the metabolic syndrome and systemic inflammation. Diabetologia. 2005;48(8):1669\u201370.","journal-title":"Diabetologia"},{"key":"2614_CR64","doi-asserted-by":"crossref","unstructured":"Yang L, Wu Y, Jin W, Mo N, Ye G, Su Z, Tang L, Wang Y, Li Y, Du J. The potential role of ferroptosis in COVID-19-related cardiovascular injury. Biomed Pharmacother 2023, 168.","DOI":"10.1016\/j.biopha.2023.115637"},{"issue":"6","key":"2614_CR65","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/hep.1840190623","volume":"19","author":"M Kobune","year":"1994","unstructured":"Kobune M, Kohgo Y, Kato J, Miyazaki E, Niitsu Y. Interleukin-6 enhances hepatic transferrin uptake and ferritin expression in rats. Hepatology (Baltimore MD). 1994;19(6):1468\u201375.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"3","key":"2614_CR66","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","volume":"142","author":"K Huynh","year":"2014","unstructured":"Huynh K, Bernardo BC, McMullen JR, Ritchie RH. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol Ther. 2014;142(3):375\u2013415.","journal-title":"Pharmacol Ther"},{"issue":"10","key":"2614_CR67","doi-asserted-by":"publisher","first-page":"25234","DOI":"10.3390\/ijms161025234","volume":"16","author":"Y Kayama","year":"2015","unstructured":"Kayama Y, Raaz U, Jagger A, Adam M, Schellinger IN, Sakamoto M, Suzuki H, Toyama K, Spin JM, Tsao PS. Diabetic Cardiovascular Disease Induced by oxidative stress. Int J Mol Sci. 2015;16(10):25234\u201363.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2614_CR68","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2020.01.018","volume":"75","author":"R Marfella","year":"2020","unstructured":"Marfella R, Amarelli C, Cacciatore F, Balestrieri ML, Mansueto G, D\u2019Onofrio N, Esposito S, Mattucci I, Salerno G, De Feo M, et al. Lipid Accumulation in hearts transplanted from nondiabetic donors to Diabetic recipients. J Am Coll Cardiol. 2020;75(11):1249\u201362.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2614_CR69","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s42255-024-01036-5","volume":"6","author":"H Wang","year":"2024","unstructured":"Wang H, Wang J, Cui H, Fan C, Xue Y, Liu H, Li H, Li J, Li H, Sun Y, et al. Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy. Nat Metabolism. 2024;6(6):1161\u201377.","journal-title":"Nat Metabolism"},{"key":"2614_CR70","doi-asserted-by":"crossref","unstructured":"Yu Y, Yan Y, Niu F, Wang Y, Chen X, Su G, Liu Y, Zhao X, Qian L, Liu P et al. Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discovery 2021, 7(1).","DOI":"10.1038\/s41420-021-00579-w"},{"issue":"7","key":"2614_CR71","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/01.RES.0000065620.39919.20","volume":"92","author":"R Candido","year":"2003","unstructured":"Candido R, Forbes JM, Thomas MC, Thallas V, Dean RG, Burns WC, Tikellis C, Ritchie RH, Twigg SM, Cooper ME, et al. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res. 2003;92(7):785\u201392.","journal-title":"Circ Res"},{"issue":"12","key":"2614_CR72","doi-asserted-by":"publisher","first-page":"e13734","DOI":"10.1111\/acel.13734","volume":"21","author":"DL Zheng","year":"2022","unstructured":"Zheng DL, Wu QR, Zeng P, Li SM, Cai YJ, Chen SZ, Luo XS, Kuang SJ, Rao F, Lai YY, et al. Advanced glycation end products induce senescence of atrial myocytes and increase susceptibility of atrial fibrillation in diabetic mice. Aging Cell. 2022;21(12):e13734.","journal-title":"Aging Cell"},{"issue":"2","key":"2614_CR73","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.apsb.2021.10.005","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Chen X, Zhou W, Men H, Bao T, Sun Y, Wang Q, Tan Y, Keller BB, Tong Q, et al. Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK\/NRF2 pathways. Acta Pharm Sin B. 2022;12(2):708\u201322.","journal-title":"Acta Pharm Sin B"},{"key":"2614_CR74","doi-asserted-by":"crossref","unstructured":"Khalid M, Petroianu G, Adem A. Advanced Glycation End products and Diabetes Mellitus: mechanisms and perspectives. Biomolecules 2022, 12(4).","DOI":"10.3390\/biom12040542"},{"key":"2614_CR75","doi-asserted-by":"crossref","unstructured":"Hu X, Bai T, Xu Z, Liu Q, Zheng Y, Cai L. Pathophysiological Fundamentals of Diabetic Cardiomyopathy. In: Comprehensive Physiology. edn.; 2017: 693\u2013711.","DOI":"10.1002\/cphy.c160021"},{"issue":"24","key":"2614_CR76","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","volume":"133","author":"CC Low Wang","year":"2016","unstructured":"Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: Cardiovascular Disease in Diabetes Mellitus. Circulation. 2016;133(24):2459\u2013502.","journal-title":"Circulation"},{"issue":"1","key":"2614_CR77","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.kint.2017.02.013","volume":"92","author":"H Noh","year":"2017","unstructured":"Noh H, Yu MR, Kim HJ, Lee JH, Park BW, Wu IH, Matsumoto M, King GL. Beta 2-adrenergic receptor agonists are novel regulators of macrophage activation in diabetic renal and cardiovascular complications. Kidney Int. 2017;92(1):101\u201313.","journal-title":"Kidney Int"},{"issue":"10","key":"2614_CR78","doi-asserted-by":"publisher","first-page":"18792","DOI":"10.1002\/jcp.28518","volume":"234","author":"X Hu","year":"2019","unstructured":"Hu X, Cai X, Ma R, Fu W, Zhang C, Du X. Iron-load exacerbates the severity of atherosclerosis via inducing inflammation and enhancing the glycolysis in macrophages. J Cell Physiol. 2019;234(10):18792\u2013800.","journal-title":"J Cell Physiol"},{"issue":"3","key":"2614_CR79","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2337\/db22-0553","volume":"72","author":"Y Chen","year":"2023","unstructured":"Chen Y, Li S, Yin M, Li Y, Chen C, Zhang J, Sun K, Kong X, Chen Z, Qian J. Isorhapontigenin attenuates Cardiac Microvascular Injury in Diabetes via the inhibition of Mitochondria-Associated Ferroptosis through PRDX2-MFN2-ACSL4 pathways. Diabetes. 2023;72(3):389\u2013404.","journal-title":"Diabetes"},{"key":"2614_CR80","doi-asserted-by":"crossref","unstructured":"Chen Z, Li S, Liu M, Yin M, Chen J, Li Y, Li Q, Zhou Y, Xia Y, Chen A et al. Nicorandil alleviates cardiac microvascular ferroptosis in diabetic cardiomyopathy: role of the mitochondria-localized AMPK-Parkin-ACSL4 signaling pathway. Pharmacol Res 2024, 200.","DOI":"10.1016\/j.phrs.2024.107057"},{"issue":"5","key":"2614_CR81","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1159\/000430173","volume":"36","author":"S Chan","year":"2015","unstructured":"Chan S, Chan GC, Ye J, Lian Q, Chen J, Yang M. Thrombopoietin protects cardiomyocytes from Iron-Overload Induced oxidative stress and mitochondrial Injury. Cell Physiol Biochemistry: Int J Experimental Cell Physiol Biochem Pharmacol. 2015;36(5):2063\u201371.","journal-title":"Cell Physiol Biochemistry: Int J Experimental Cell Physiol Biochem Pharmacol"},{"key":"2614_CR82","doi-asserted-by":"crossref","unstructured":"Gordan R, Fefelova N, Gwathmey JK, Xie LH. Iron overload, oxidative stress and calcium mishandling in Cardiomyocytes: role of the mitochondrial permeability transition pore. Antioxid (Basel) 2020, 9(8).","DOI":"10.3390\/antiox9080758"},{"key":"2614_CR83","doi-asserted-by":"publisher","first-page":"104817","DOI":"10.1016\/j.tiv.2020.104817","volume":"65","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Chen S, Li H, Yang B, Chen T, Hu T, Yin D, He H, He M. Tetramethylpyrazine alleviates iron overload damage in vascular endothelium via upregulating DDAHII expression. Toxicol vitro: Int J Published Association BIBRA. 2020;65:104817.","journal-title":"Toxicol vitro: Int J Published Association BIBRA"},{"key":"2614_CR84","doi-asserted-by":"publisher","first-page":"172885","DOI":"10.1016\/j.ejphar.2019.172885","volume":"868","author":"X Chen","year":"2020","unstructured":"Chen X, Li H, Wang Z, Zhou Q, Chen S, Yang B, Yin D, He H, He M. Quercetin protects the vascular endothelium against iron overload damages via ROS\/ADMA\/DDAHII\/eNOS\/NO pathway. Eur J Pharmacol. 2020;868:172885.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2614_CR85","doi-asserted-by":"publisher","first-page":"112552","DOI":"10.1016\/j.yexcr.2021.112552","volume":"402","author":"D Wang","year":"2021","unstructured":"Wang D, Ye P, Kong C, Chao Y, Yu W, Jiang X, Luo J, Gu Y, Chen SL. Mitoferrin 2 deficiency prevents mitochondrial iron overload-induced endothelial injury and alleviates atherosclerosis. Exp Cell Res. 2021;402(1):112552.","journal-title":"Exp Cell Res"},{"issue":"4\u20135","key":"2614_CR86","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.lfs.2013.01.004","volume":"92","author":"J Sripetchwandee","year":"2013","unstructured":"Sripetchwandee J, Sanit J, Chattipakorn N, Chattipakorn SC. Mitochondrial calcium uniporter blocker effectively prevents brain mitochondrial dysfunction caused by iron overload. Life Sci. 2013;92(4\u20135):298\u2013304.","journal-title":"Life Sci"},{"issue":"2","key":"2614_CR87","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/apha.12162","volume":"210","author":"J Sripetchwandee","year":"2014","unstructured":"Sripetchwandee J, KenKnight SB, Sanit J, Chattipakorn S, Chattipakorn N. Blockade of mitochondrial calcium uniporter prevents cardiac mitochondrial dysfunction caused by iron overload. Acta Physiologica (Oxford England). 2014;210(2):330\u201341.","journal-title":"Acta Physiologica (Oxford England)"},{"issue":"1","key":"2614_CR88","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00395-023-00990-7","volume":"118","author":"N Fefelova","year":"2023","unstructured":"Fefelova N, Wongjaikam S, Pamarthi SH, Siri-Angkul N, Comollo T, Kumari A, Garg V, Ivessa A, Chattipakorn SC, Chattipakorn N, et al. Deficiency of mitochondrial calcium uniporter abrogates iron overload-induced cardiac dysfunction by reducing ferroptosis. Basic Res Cardiol. 2023;118(1):21.","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"2614_CR89","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12012-010-9101-z","volume":"11","author":"K Charradi","year":"2011","unstructured":"Charradi K, Sebai H, Elkahoui S, Ben Hassine F, Limam F, Aouani E. Grape seed extract alleviates high-fat diet-induced obesity and heart dysfunction by preventing cardiac siderosis. Cardiovasc Toxicol. 2011;11(1):28\u201337.","journal-title":"Cardiovasc Toxicol"},{"issue":"1","key":"2614_CR90","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1038\/s41598-023-42550-y","volume":"13","author":"SAE Bashandy","year":"2023","unstructured":"Bashandy SAE, El-Seidy AMA, Ibrahim FAA, Abdelrahman SS, Abdelmottaleb Moussa SA, ElBaset MA. Zinc nanoparticles ameliorated obesity-induced cardiovascular disease: role of metabolic syndrome and iron overload. Sci Rep. 2023;13(1):16010.","journal-title":"Sci Rep"},{"key":"2614_CR91","doi-asserted-by":"publisher","first-page":"1248934","DOI":"10.3389\/fendo.2023.1248934","volume":"14","author":"D Zhou","year":"2023","unstructured":"Zhou D, Lu P, Mo X, Yang B, Chen T, Yao Y, Xiong T, Yue L, Yang X. Ferroptosis and metabolic syndrome and complications: association, mechanism, and translational applications. Front Endocrinol. 2023;14:1248934.","journal-title":"Front Endocrinol"},{"key":"2614_CR92","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2023.03.003","volume":"201","author":"M Zhu","year":"2023","unstructured":"Zhu M, Peng L, Huo S, Peng D, Gou J, Shi W, Tao J, Jiang T, Jiang Y, Wang Q, et al. STAT3 signaling promotes cardiac injury by upregulating NCOA4-mediated ferritinophagy and ferroptosis in high-fat-diet fed mice. Free Radic Biol Med. 2023;201:111\u201325.","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"2614_CR93","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1093\/jn\/137.11.2366","volume":"137","author":"B Chung","year":"2007","unstructured":"Chung B, Matak P, McKie AT, Sharp P. Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr. 2007;137(11):2366\u201370.","journal-title":"J Nutr"},{"issue":"1","key":"2614_CR94","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.124.070535","volume":"151","author":"NWS Chew","year":"2025","unstructured":"Chew NWS, Mehta A, Goh RSJ, Zhang A, Chen Y, Chong B, Chew HSJ, Shabbir A, Brown A, Dimitriadis GK, et al. Cardiovascular-Liver-Metabolic Health: recommendations in screening, diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach. Circulation. 2025;151(1):98\u2013119.","journal-title":"Circulation"},{"key":"2614_CR95","doi-asserted-by":"crossref","unstructured":"Zheng H, Sechi LA, Navarese EP, Casu G, Vidili G. Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review. Cardiovasc Diabetol 2024, 23(1).","DOI":"10.1186\/s12933-024-02434-5"},{"issue":"8","key":"2614_CR96","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","volume":"73","author":"EP Stahl","year":"2019","unstructured":"Stahl EP, Dhindsa DS, Lee SK, Sandesara PB, Chalasani NP, Sperling LS. Nonalcoholic fatty liver Disease and the heart. J Am Coll Cardiol. 2019;73(8):948\u201363.","journal-title":"J Am Coll Cardiol"},{"key":"2614_CR97","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2022.01.020","volume":"181","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Tang J, Song J, Xie M, Liu Y, Dong Z, Liu X, Li X, Zhang M, Chen Y, et al. Elabela alleviates ferroptosis, myocardial remodeling, fibrosis and heart dysfunction in hypertensive mice by modulating the IL-6\/STAT3\/GPX4 signaling. Free Radic Biol Med. 2022;181:130\u201342.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"2614_CR98","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4239\/wjd.v12.i2.124","volume":"12","author":"EF Luo","year":"2021","unstructured":"Luo EF, Li HX, Qin YH, Qiao Y, Yan GL, Yao YY, Li LQ, Hou JT, Tang CC, Wang D. Role of ferroptosis in the process of diabetes-induced endothelial dysfunction. World J Diabetes. 2021;12(2):124\u201337.","journal-title":"World J Diabetes"},{"issue":"9","key":"2614_CR99","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1161\/ATVBAHA.114.303035","volume":"34","author":"S Lim","year":"2014","unstructured":"Lim S, Meigs JB. Links between ectopic fat and vascular disease in humans. Arterioscler Thromb Vasc Biol. 2014;34(9):1820\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2614_CR100","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s12020-021-02933-5","volume":"75","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Hu Q, Wu J. Adiponectin ameliorates placental injury in gestational diabetes mice by correcting fatty acid oxidation\/peroxide imbalance-induced ferroptosis via restoration of CPT-1 activity. Endocrine. 2022;75(3):781\u201393.","journal-title":"Endocrine"},{"key":"2614_CR101","doi-asserted-by":"publisher","first-page":"109416","DOI":"10.1016\/j.jnutbio.2023.109416","volume":"120","author":"F Li","year":"2023","unstructured":"Li F, Hao S, Gao J, Jiang P. EGCG alleviates obesity-exacerbated lung cancer progression by STAT1\/SLC7A11 pathway and gut microbiota. J Nutr Biochem. 2023;120:109416.","journal-title":"J Nutr Biochem"},{"issue":"5","key":"2614_CR102","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/hep4.1333","volume":"3","author":"Z Zhou","year":"2019","unstructured":"Zhou Z, Ye TJ, Bonavita G, Daniels M, Kainrad N, Jogasuria A, You M. Adipose-specific Lipin-1 overexpression renders hepatic ferroptosis and exacerbates alcoholic steatohepatitis in mice. Hepatol Commun. 2019;3(5):656\u201369.","journal-title":"Hepatol Commun"},{"issue":"11","key":"2614_CR103","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41419-019-2061-8","volume":"10","author":"TJ Park","year":"2019","unstructured":"Park TJ, Park JH, Lee GS, Lee JY, Shin JH, Kim MW, Kim YS, Kim JY, Oh KJ, Han BS, et al. Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes. Cell Death Dis. 2019;10(11):835.","journal-title":"Cell Death Dis"},{"key":"2614_CR104","doi-asserted-by":"crossref","unstructured":"Kraml P. The role of Iron in the pathogenesis of atherosclerosis. Physiol Res 2017:S55\u201367.","DOI":"10.33549\/physiolres.933589"},{"issue":"5","key":"2614_CR105","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1161\/01.ATV.0000124892.90999.cb","volume":"24","author":"N Stadler","year":"2004","unstructured":"Stadler N, Lindner RA, Davies MJ. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol. 2004;24(5):949\u201354.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"2614_CR106","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.freeradbiomed.2005.12.031","volume":"40","author":"N Stanley","year":"2006","unstructured":"Stanley N, Stadler N, Woods AA, Bannon PG, Davies MJ. Concentrations of iron correlate with the extent of protein, but not lipid, oxidation in advanced human atherosclerotic lesions. Free Radic Biol Med. 2006;40(9):1636\u201343.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"2614_CR107","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.atherosclerosis.2012.03.015","volume":"222","author":"N Stadler","year":"2012","unstructured":"Stadler N, Heeneman S, V\u00f6\u00f6 S, Stanley N, Giles GI, Gang BP, Croft KD, Mori TA, Vacata V, Daemen MJ, et al. Reduced metal ion concentrations in atherosclerotic plaques from subjects with type 2 diabetes mellitus. Atherosclerosis. 2012;222(2):512\u20138.","journal-title":"Atherosclerosis"},{"issue":"12","key":"2614_CR108","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.yjmcc.2003.09.007","volume":"35","author":"H Farhangkhoee","year":"2003","unstructured":"Farhangkhoee H, Khan ZA, Mukherjee S, Cukiernik M, Barbin YP, Karmazyn M, Chakrabarti S. Heme oxygenase in diabetes-induced oxidative stress in the heart. J Mol Cell Cardiol. 2003;35(12):1439\u201348.","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"2614_CR109","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1089\/ars.2008.2043","volume":"10","author":"A Loboda","year":"2008","unstructured":"Loboda A, Jazwa A, Grochot-Przeczek A, Rutkowski AJ, Cisowski J, Agarwal A, Jozkowicz A, Dulak J. Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2008;10(10):1767\u2013812.","journal-title":"Antioxid Redox Signal"},{"issue":"12","key":"2614_CR110","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jacc.2008.06.019","volume":"52","author":"NK Idriss","year":"2008","unstructured":"Idriss NK, Blann AD, Lip GY. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol. 2008;52(12):971\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2614_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-002-0769-4","volume":"111","author":"Y-H Chen","year":"2002","unstructured":"Chen Y-H, Lin S-J, Lin M-W, Tsai H-L, Kuo S-S, Chen J-W, Charng M-J, Wu T-C, Chen L-C, Ding P, et al. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet. 2002;111(1):1\u20138.","journal-title":"Hum Genet"},{"issue":"1","key":"2614_CR112","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41420-024-02044-w","volume":"10","author":"FI Gawargi","year":"2024","unstructured":"Gawargi FI, Mishra PK. Regulation of cardiac ferroptosis in diabetic human heart failure: uncovering molecular pathways and key targets. Cell Death Discov. 2024;10(1):268.","journal-title":"Cell Death Discov"},{"key":"2614_CR113","doi-asserted-by":"publisher","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107.","journal-title":"Redox Biol"},{"key":"2614_CR114","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.freeradbiomed.2021.12.001","volume":"179","author":"QM Chen","year":"2022","unstructured":"Chen QM. Nrf2 for protection against oxidant generation and mitochondrial damage in cardiac injury. Free Radic Biol Med. 2022;179:133\u201343.","journal-title":"Free Radic Biol Med"},{"key":"2614_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/8373389","volume":"2022","author":"W Miao","year":"2022","unstructured":"Miao W, Chen M, Chen M, Cui C, Zhu Y, Luo X, Wu B, Dobrzyn A. Nr2f2 overexpression aggravates ferroptosis and mitochondrial dysfunction by regulating the PGC-1\u03b1 signaling in Diabetes-Induced Heart failure mice. Mediat Inflamm. 2022;2022:1\u201313.","journal-title":"Mediat Inflamm"},{"issue":"2","key":"2614_CR116","doi-asserted-by":"publisher","first-page":"166301","DOI":"10.1016\/j.bbadis.2021.166301","volume":"1868","author":"N Sumneang","year":"2022","unstructured":"Sumneang N, Oo TT, Singhanat K, Maneechote C, Arunsak B, Nawara W, Pratchayasakul W, Benjanuwattra J, Apaijai N, Liang G, et al. Inhibition of myeloid differentiation factor 2 attenuates cardiometabolic impairments via reducing cardiac mitochondrial dysfunction, inflammation, apoptosis and ferroptosis in prediabetic rats. Biochim et Biophys acta Mol Basis Disease. 2022;1868(2):166301.","journal-title":"Biochim et Biophys acta Mol Basis Disease"},{"issue":"12","key":"2614_CR117","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1111\/jcmm.15318","volume":"24","author":"C Wang","year":"2020","unstructured":"Wang C, Zhu L, Yuan W, Sun L, Xia Z, Zhang Z, Yao W. Diabetes aggravates myocardial ischaemia reperfusion injury via activating Nox2-related programmed cell death in an AMPK-dependent manner. J Cell Mol Med. 2020;24(12):6670\u20139.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"2614_CR118","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1089\/dna.2019.5097","volume":"39","author":"W Li","year":"2020","unstructured":"Li W, Li W, Leng Y, Xiong Y, Xia Z. Ferroptosis is involved in diabetes myocardial Ischemia\/Reperfusion Injury through endoplasmic reticulum stress. DNA Cell Biol. 2020;39(2):210\u201325.","journal-title":"DNA Cell Biol"},{"issue":"2","key":"2614_CR119","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12192-022-01257-1","volume":"27","author":"H Tian","year":"2021","unstructured":"Tian H, Xiong Y, Zhang Y, Leng Y, Tao J, Li L, Qiu Z, Xia Z. Activation of NRF2\/FPN1 pathway attenuates myocardial ischemia-reperfusion injury in diabetic rats by regulating iron homeostasis and ferroptosis. Cell Stress Chaperones. 2021;27(2):149\u201364.","journal-title":"Cell Stress Chaperones"},{"key":"2614_CR120","doi-asserted-by":"crossref","unstructured":"Seferovi\u0107 PM, Paulus WJ, Rosano G, Polovina M, Petrie MC, Jhund PS, Tsch\u00f6pe C, Sattar N, Piepoli M, Papp Z et al. Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases. Eur J Heart Fail 2024.","DOI":"10.1002\/ejhf.3347"},{"key":"2614_CR121","doi-asserted-by":"crossref","unstructured":"Du S, Shi H, Xiong L, Wang P, Shi Y. Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy. Front Endocrinol 2022, 13.","DOI":"10.3389\/fendo.2022.1011669"},{"key":"2614_CR122","doi-asserted-by":"publisher","first-page":"106086","DOI":"10.1016\/j.phrs.2022.106086","volume":"176","author":"L Chen","year":"2022","unstructured":"Chen L, Yin Z, Qin X, Zhu X, Chen X, Ding G, Sun D, Wu NN, Fei J, Bi Y, et al. CD74 ablation rescues type 2 diabetes mellitus-induced cardiac remodeling and contractile dysfunction through pyroptosis-evoked regulation of ferroptosis. Pharmacol Res. 2022;176:106086.","journal-title":"Pharmacol Res"},{"key":"2614_CR123","doi-asserted-by":"publisher","first-page":"112605","DOI":"10.1016\/j.intimp.2024.112605","volume":"138","author":"X Zhang","year":"2024","unstructured":"Zhang X, Dong X, Jie H, Li S, Li H, Su Y, Li L, Kang L, Dong B, Zhang Y. Downregulation of the (pro)renin receptor alleviates ferroptosis-associated cardiac pathological changes via the NCOA 4-mediated ferritinophagy pathway in diabetic cardiomyopathy. Int Immunopharmacol. 2024;138:112605.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"2614_CR124","first-page":"825","volume":"23","author":"J Sun","year":"2023","unstructured":"Sun J, Xu J, Liu Y, Lin Y, Wang F, Han Y, Zhang S, Gao X, Xu C, Yuan H. Exogenous spermidine alleviates diabetic cardiomyopathy via suppressing reactive oxygen species, endoplasmic reticulum stress, and Pannexin-1-mediated ferroptosis. Biomolecules Biomed. 2023;23(5):825\u201337.","journal-title":"Biomolecules Biomed"},{"key":"2614_CR125","doi-asserted-by":"crossref","unstructured":"Zhao M, Shen Z, Zheng Z, Xu Y, Zhang J, Liu J, Peng S, Wan J, Qin JJ, Wang M. Cardiomyocyte LGR6 alleviates ferroptosis in diabetic cardiomyopathy via regulating mitochondrial biogenesis. Metab Clin Exp 2024:155979.","DOI":"10.1016\/j.metabol.2024.155979"},{"key":"2614_CR126","doi-asserted-by":"crossref","unstructured":"Chen Y, Li S, Guan B, Yan X, Huang C, Du Y, Yang F, Zhang N, Li Y, Lu J et al. MAP4K4 exacerbates cardiac microvascular injury in diabetes by facilitating S-nitrosylation modification of Drp1. Cardiovasc Diabetol 2024, 23(1).","DOI":"10.1186\/s12933-024-02254-7"},{"key":"2614_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/3027514","volume":"2022","author":"S Wu","year":"2022","unstructured":"Wu S, Zhu J, Wu G, Hu Z, Ying P, Bao Z, Ding Z, Tan X, W\u0119grzyn G. 6-Gingerol alleviates ferroptosis and Inflammation of Diabetic Cardiomyopathy via the Nrf2\/HO-1 pathway. Oxidative Med Cell Longev. 2022;2022:1\u201312.","journal-title":"Oxidative Med Cell Longev"},{"key":"2614_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/2371401","volume":"2022","author":"Z Wei","year":"2022","unstructured":"Wei Z, Shaohuan Q, Pinfang K, Chao S, Gasparotto Junior A. Curcumin attenuates Ferroptosis-Induced Myocardial Injury in Diabetic Cardiomyopathy through the Nrf2 pathway. Cardiovasc Ther. 2022;2022:1\u201311.","journal-title":"Cardiovasc Ther"},{"key":"2614_CR129","doi-asserted-by":"crossref","unstructured":"Tian H, Huang Q, Cheng J, Xiong Y, Xia Z. Rev-erb\u03b1 attenuates diabetic myocardial injury through regulation of ferroptosis. Cell Signal 2024, 114.","DOI":"10.1016\/j.cellsig.2023.111006"},{"key":"2614_CR130","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.freeradbiomed.2023.11.032","volume":"210","author":"S Wu","year":"2024","unstructured":"Wu S, Zhou Y, Liang J, Ying P, Situ Q, Tan X, Zhu J. Upregulation of NF-\u03baB by USP24 aggravates ferroptosis in diabetic cardiomyopathy. Free Radic Biol Med. 2024;210:352\u201366.","journal-title":"Free Radic Biol Med"},{"key":"2614_CR131","doi-asserted-by":"crossref","unstructured":"Zhen J, Sheng X, Chen T, Yu H. Histone acetyltransferase Kat2a regulates ferroptosis via enhancing Tfrc and Hmox1 expression in diabetic cardiomyopathy. Cell Death Dis 2024, 15(6).","DOI":"10.1038\/s41419-024-06771-x"},{"issue":"1","key":"2614_CR132","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41467-023-36837-x","volume":"14","author":"Y Wu","year":"2023","unstructured":"Wu Y, Huang T, Li X, Shen C, Ren H, Wang H, Wu T, Fu X, Deng S, Feng Z, et al. Retinol dehydrogenase 10 reduction mediated retinol metabolism disorder promotes diabetic cardiomyopathy in male mice. Nat Commun. 2023;14(1):1181.","journal-title":"Nat Commun"},{"key":"2614_CR133","doi-asserted-by":"publisher","first-page":"114993","DOI":"10.1016\/j.biopha.2023.114993","volume":"164","author":"Y Liu","year":"2023","unstructured":"Liu Y, Ding W, Wang J, Ao X, Xue J. Non-coding RNA-mediated modulation of ferroptosis in cardiovascular diseases. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie. 2023;164:114993.","journal-title":"Biomed Pharmacotherapy = Biomedecine Pharmacotherapie"},{"issue":"1","key":"2614_CR134","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12933-024-02204-3","volume":"23","author":"X Ni","year":"2024","unstructured":"Ni X, Duan L, Bao Y, Li J, Zhang X, Jia D, Wu N. Circ_005077 accelerates myocardial lipotoxicity induced by high-fat diet via CyPA\/p47PHOX mediated ferroptosis. Cardiovasc Diabetol. 2024;23(1):129.","journal-title":"Cardiovasc Diabetol"},{"issue":"10296","key":"2614_CR135","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","volume":"398","author":"E Brown","year":"2021","unstructured":"Brown E, Heerspink HJL, Cuthbertson DJ, Wilding JPH. SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications. Lancet. 2021;398(10296):262\u201376.","journal-title":"Lancet"},{"issue":"4","key":"2614_CR136","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCULATIONAHA.120.051824","volume":"143","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Khan MS, Marx N, Lam CSP, Schnaidt S, Ofstad AP, Brueckmann M, Jamal W, et al. Effect of Empagliflozin on Cardiovascular and renal outcomes in patients with Heart failure by Baseline Diabetes Status. Circulation. 2021;143(4):337\u201349.","journal-title":"Circulation"},{"issue":"9","key":"2614_CR137","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/CIRCULATIONAHA.122.059785","volume":"146","author":"G Filippatos","year":"2022","unstructured":"Filippatos G, Butler J, Farmakis D, Zannad F, Ofstad AP, Ferreira JP, Green JB, Rosenstock J, Schnaidt S, Brueckmann M, et al. Empagliflozin for Heart failure with preserved left ventricular ejection Fraction with and without diabetes. Circulation. 2022;146(9):676\u201386.","journal-title":"Circulation"},{"key":"2614_CR138","doi-asserted-by":"publisher","first-page":"176934","DOI":"10.1016\/j.ejphar.2024.176934","volume":"982","author":"H Asil","year":"2024","unstructured":"Asil H, Demiry\u00fcrek AT, D\u00fczen IV, B\u00fcy\u00fckcelebi O, Saracaloglu A, Demirkiran C, Demiry\u00fcrek \u015e. Effects of empagliflozin and dapagliflozin on serum humanin, MOTS-c levels, nitrosative stress, and ferroptosis parameters in diabetic patients with heart failure. Eur J Pharmacol. 2024;982:176934.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2614_CR139","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12933-024-02298-9","volume":"23","author":"BJ Kasperova","year":"2024","unstructured":"Kasperova BJ, Mraz M, Svoboda P, Hlavacek D, Kratochvilova H, Modos I, Vrzackova N, Ivak P, Janovska P, Kobets T, et al. Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure. Cardiovasc Diabetol. 2024;23(1):223.","journal-title":"Cardiovasc Diabetol"},{"key":"2614_CR140","doi-asserted-by":"crossref","unstructured":"Wan F, He X, Xie W. Canagliflozin inhibits Palmitic Acid-Induced Vascular Cell Aging in Vitro through ROS\/ERK and Ferroptosis Pathways. Antioxid (Basel) 2024, 13(7).","DOI":"10.3390\/antiox13070831"},{"key":"2614_CR141","doi-asserted-by":"crossref","unstructured":"Zhang W, Lu J, Wang Y, Sun P, Gao T, Xu N, Zhang Y, Xie W. Canagliflozin attenuates lipotoxicity in Cardiomyocytes by inhibiting inflammation and Ferroptosis through activating AMPK Pathway. Int J Mol Sci 2023, 24(1).","DOI":"10.3390\/ijms24010858"},{"key":"2614_CR142","doi-asserted-by":"publisher","first-page":"1078205","DOI":"10.3389\/fphar.2023.1078205","volume":"14","author":"W Chen","year":"2023","unstructured":"Chen W, Zhang Y, Wang Z, Tan M, Lin J, Qian X, Li H, Jiang T. Dapagliflozin alleviates myocardial ischemia\/reperfusion injury by reducing ferroptosis via MAPK signaling inhibition. Front Pharmacol. 2023;14:1078205.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2614_CR143","doi-asserted-by":"publisher","first-page":"13851","DOI":"10.1038\/s41598-024-64909-5","volume":"14","author":"L Wang","year":"2024","unstructured":"Wang L, Wang Y, Xu H, Li W. Effect of dapagliflozin on ferroptosis through the gut microbiota metabolite TMAO during myocardial ischemia-reperfusion injury in diabetes mellitus rats. Sci Rep. 2024;14(1):13851.","journal-title":"Sci Rep"},{"issue":"7","key":"2614_CR144","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","volume":"20","author":"JR Ussher","year":"2023","unstructured":"Ussher JR, Drucker DJ. Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action. Nat Reviews Cardiol. 2023;20(7):463\u201374.","journal-title":"Nat Reviews Cardiol"},{"key":"2614_CR145","doi-asserted-by":"crossref","unstructured":"Tian S, Zhou S, Wu W, Lin Y, Wang T, Sun H, AS AN-W, Li Y, Wang C, Li X et al. GLP-1 Receptor Agonists Alleviate Diabetic Kidney Injury via \u03b2-Klotho-Mediated Ferroptosis Inhibition. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024:e2409781.","DOI":"10.1002\/advs.202409781"},{"key":"2614_CR146","doi-asserted-by":"crossref","unstructured":"Sun Z, Zhang F, Gao Z, Wu J, Bi Q, Zheng X, Zhang J, Cao P, Wang W. Liraglutide alleviates ferroptosis in renal ischemia reperfusion injury via inhibiting macrophage extracellular trap formation. Int Immunopharmacol 2024, 142(Pt B):113258.","DOI":"10.1016\/j.intimp.2024.113258"},{"issue":"4","key":"2614_CR147","doi-asserted-by":"publisher","first-page":"167060","DOI":"10.1016\/j.bbadis.2024.167060","volume":"1870","author":"R Shen","year":"2024","unstructured":"Shen R, Qin S, Lv Y, Liu D, Ke Q, Shi C, Jiang L, Yang J, Zhou Y. GLP-1 receptor agonist attenuates tubular cell ferroptosis in diabetes via enhancing AMPK-fatty acid metabolism pathway through macropinocytosis. Biochim et Biophys acta Mol Basis Disease. 2024;1870(4):167060.","journal-title":"Biochim et Biophys acta Mol Basis Disease"},{"key":"2614_CR148","doi-asserted-by":"publisher","first-page":"103468","DOI":"10.1016\/j.redox.2024.103468","volume":"79","author":"C Lu","year":"2024","unstructured":"Lu C, Xu C, Li S, Ni H, Yang J. Liraglutide and GLP-1(9\u201337) alleviated hepatic ischemia-reperfusion injury by inhibiting ferroptosis via GSK3\u03b2\/Nrf2 pathway and SMAD159\/Hepcidin\/FTH pathway. Redox Biol. 2024;79:103468.","journal-title":"Redox Biol"},{"issue":"1","key":"2614_CR149","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s10020-023-00721-7","volume":"29","author":"T Guo","year":"2023","unstructured":"Guo T, Yan W, Cui X, Liu N, Wei X, Sun Y, Fan K, Liu J, Zhu Y, Wang Z, et al. Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK\/ACC signaling and inhibiting ferroptosis. Mol Med (Cambridge Mass). 2023;29(1):132.","journal-title":"Mol Med (Cambridge Mass)"},{"key":"2614_CR150","doi-asserted-by":"publisher","first-page":"177029","DOI":"10.1016\/j.ejphar.2024.177029","volume":"984","author":"W Yu","year":"2024","unstructured":"Yu W, Lu J, Huang X, Zhuang H, An Y, Zhang M. Exendin-4 promotes ischemia-reperfusion flap survival by upregulating Gpx4 to inhibit ferroptosis. Eur J Pharmacol. 2024;984:177029.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2614_CR151","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11064-021-03442-7","volume":"47","author":"JR An","year":"2022","unstructured":"An JR, Su JN, Sun GY, Wang QF, Fan YD, Jiang N, Yang YF, Shi Y. Liraglutide alleviates cognitive deficit in db\/db mice: involvement in oxidative stress, Iron overload, and Ferroptosis. Neurochem Res. 2022;47(2):279\u201394.","journal-title":"Neurochem Res"},{"key":"2614_CR152","doi-asserted-by":"crossref","unstructured":"Boshchenko AA, Maslov LN, Mukhomedzyanov AV, Zhuravleva OA, Slidnevskaya AS, Naryzhnaya NV, Zinovieva AS, Ilinykh PA. Peptides are cardioprotective drugs of the future: the receptor and signaling mechanisms of the cardioprotective effect of glucagon-like Peptide-1 receptor agonists. Int J Mol Sci 2024, 25(9).","DOI":"10.3390\/ijms25094900"},{"issue":"4","key":"2614_CR153","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s12265-020-09984-5","volume":"14","author":"RA Eid","year":"2020","unstructured":"Eid RA, Bin-Meferij MM, El-kott AF, Eleawa SM, Zaki MSA, Al-Shraim M, El-Sayed F, Eldeen MA, Alkhateeb MA, Alharbi SA, et al. Exendin-4 protects against myocardial ischemia-reperfusion Injury by Upregulation of SIRT1 and SIRT3 and activation of AMPK. J Cardiovasc Transl Res. 2020;14(4):619\u201335.","journal-title":"J Cardiovasc Transl Res"},{"key":"2614_CR154","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.freeradbiomed.2016.03.035","volume":"95","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhou H, Wu W, Shi C, Hu S, Yin T, Ma Q, Han T, Zhang Y, Tian F, et al. Liraglutide protects cardiac microvascular endothelial cells against hypoxia\/reoxygenation injury through the suppression of the SR-Ca2+\u2013XO\u2013ROS axis via activation of the GLP-1R\/PI3K\/Akt\/survivin pathways. Free Radic Biol Med. 2016;95:278\u201392.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"2614_CR155","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1210\/jc.2014-2291","volume":"100","author":"M Rizzo","year":"2015","unstructured":"Rizzo M, Abate N, Chandalia M, Rizvi AA, Giglio RV, Nikolic D, Marino Gammazza A, Barbagallo I, Isenovic ER, Banach M, et al. Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study. J Clin Endocrinol Metab. 2015;100(2):603\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2614_CR156","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2337\/db22-0745","volume":"72","author":"J Liu","year":"2023","unstructured":"Liu J, Aylor KW, Liu Z. Liraglutide and Exercise synergistically attenuate vascular inflammation and Enhance Metabolic Insulin Action in early Diet-Induced obesity. Diabetes. 2023;72(7):918\u201331.","journal-title":"Diabetes"},{"issue":"17","key":"2614_CR157","doi-asserted-by":"publisher","first-page":"10245","DOI":"10.1039\/C9RA09959J","volume":"10","author":"M Xiao","year":"2020","unstructured":"Xiao M, Lu D, Tian J, Yu Y, Zhang Q, Zhang L, Chang D. The protective effects of GLP-1 receptor agonist lixisenatide on oxygen-glucose deprivation\/reperfusion (OGD\/R)-induced deregulation of endothelial tube formation. RSC Adv. 2020;10(17):10245\u201353.","journal-title":"RSC Adv"},{"issue":"7","key":"2614_CR158","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/ATVBAHA.110.206425","volume":"30","author":"H Oeseburg","year":"2010","unstructured":"Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Sillj\u00e9 HH. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. Arterioscler Thromb Vasc Biol. 2010;30(7):1407\u201314.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2614_CR159","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2337\/db08-1193","volume":"58","author":"MH Noyan-Ashraf","year":"2009","unstructured":"Noyan-Ashraf MH, Momen MA, Ban K, Sadi AM, Zhou YQ, Riazi AM, Baggio LL, Henkelman RM, Husain M, Drucker DJ. GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes. 2009;58(4):975\u201383.","journal-title":"Diabetes"},{"issue":"2","key":"2614_CR160","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4077\/CJP.2017.BAF434","volume":"60","author":"SM Zhao","year":"2017","unstructured":"Zhao SM, Gao HL, Wang YL, Xu Q, Guo CY. Attenuation of high glucose-Induced Rat Cardiomyocyte apoptosis by Exendin-4 via intervention of HO-1\/Nrf-2 and the PI3K\/AKT signaling pathway. Chin J Physiol. 2017;60(2):89\u201396.","journal-title":"Chin J Physiol"},{"issue":"4","key":"2614_CR161","doi-asserted-by":"publisher","first-page":"C572","DOI":"10.1152\/ajpcell.00093.2016","volume":"311","author":"T Zhou","year":"2016","unstructured":"Zhou T, Zhang M, Zhao L, Li A, Qin X. Activation of Nrf2 contributes to the protective effect of Exendin-4 against angiotensin II-induced vascular smooth muscle cell senescence. Am J Physiol Cell Physiol. 2016;311(4):C572\u201382.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"2614_CR162","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41421-023-00595-3","volume":"9","author":"Z Cai","year":"2023","unstructured":"Cai Z, Wu X, Song Z, Sun S, Su Y, Wang T, Cheng X, Yu Y, Yu C, Chen E, et al. Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosis. Cell Discovery. 2023;9(1):104.","journal-title":"Cell Discovery"},{"key":"2614_CR163","doi-asserted-by":"publisher","first-page":"122960","DOI":"10.1016\/j.biomaterials.2024.122960","volume":"315","author":"P Ye","year":"2025","unstructured":"Ye P, Wang C, Wen Y, Fang K, Li Q, Zhang X, Yang J, Li R, Chen M, Tong X, et al. A positive-feedback loop suppresses TNBC tumour growth by remodeling tumour immune microenvironment and inducing ferroptosis. Biomaterials. 2025;315:122960.","journal-title":"Biomaterials"},{"issue":"1","key":"2614_CR164","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13046-021-02012-7","volume":"40","author":"J Yang","year":"2021","unstructured":"Yang J, Zhou Y, Xie S, Wang J, Li Z, Chen L, Mao M, Chen C, Huang A, Chen Y, et al. Metformin induces ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer. J Experimental Clin cancer Research: CR. 2021;40(1):206.","journal-title":"J Experimental Clin cancer Research: CR"},{"issue":"19","key":"2614_CR165","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/s41388-023-02665-y","volume":"42","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiong L, Wei T, Liu Q, Yan L, Chen J, Dai L, Shi L, Zhang W, Yang J, et al. Hypoxia-responsive PPARGC1A\/BAMBI\/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma. Oncogene. 2023;42(19):1509\u201323.","journal-title":"Oncogene"},{"key":"2614_CR166","doi-asserted-by":"crossref","unstructured":"Zou Z, Hu W, Kang F, Xu Z, Li Y, Zhang J, Li J, Zhang Y, Dong S. Interplay between lipid dysregulation and ferroptosis in chondrocytes and the targeted therapy effect of metformin on osteoarthritis. J Adv Res 2024.","DOI":"10.1016\/j.jare.2024.04.012"},{"key":"2614_CR167","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.freeradbiomed.2023.02.013","volume":"199","author":"H Guo","year":"2023","unstructured":"Guo H, Fang T, Cheng Y, Li T, Qu JR, Xu CF, Deng XQ, Sun B, Chen LM. ChREBP-\u03b2\/TXNIP aggravates frucose-induced renal injury through triggering ferroptosis of renal tubular epithelial cells. Free Radic Biol Med. 2023;199:154\u201365.","journal-title":"Free Radic Biol Med"},{"key":"2614_CR168","doi-asserted-by":"publisher","first-page":"115835","DOI":"10.1016\/j.biopha.2023.115835","volume":"168","author":"Y Sun","year":"2023","unstructured":"Sun Y, Bai YP, Wang DG, Xing YJ, Zhang T, Wang W, Zhou SM, Cheng JH, Chang WW, Kong X, et al. Protective effects of metformin on pancreatic \u03b2-cell ferroptosis in type 2 diabetes in vivo. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie. 2023;168:115835.","journal-title":"Biomed Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"2614_CR169","doi-asserted-by":"publisher","first-page":"175967","DOI":"10.1016\/j.ejphar.2023.175967","volume":"956","author":"Y Sun","year":"2023","unstructured":"Sun Y, Guo LQ, Wang DG, Xing YJ, Bai YP, Zhang T, Wang W, Zhou SM, Yao XM, Cheng JH, et al. Metformin alleviates\u2002glucolipotoxicity-induced pancreatic \u03b2 cell ferroptosis through regulation of the GPX4\/ACSL4 axis. Eur J Pharmacol. 2023;956:175967.","journal-title":"Eur J Pharmacol"},{"key":"2614_CR170","doi-asserted-by":"crossref","unstructured":"Yue F, Shi Y, Wu S, Xing L, He D, Wei L, Qiu A, Russell R, Zhang D. Metformin alleviates hepatic iron overload and ferroptosis through AMPK-ferroportin pathway in HFD-induced NAFLD. iScience 2023, 26(12):108560.","DOI":"10.1016\/j.isci.2023.108560"},{"key":"2614_CR171","doi-asserted-by":"publisher","first-page":"176341","DOI":"10.1016\/j.ejphar.2024.176341","volume":"966","author":"T Zhang","year":"2024","unstructured":"Zhang T, Wang MY, Wang GD, Lv QY, Huang YQ, Zhang P, Wang W, Zhang Y, Bai YP, Guo LQ. Metformin improves\u2002nonalcoholic fatty liver disease in db\/db mice by inhibiting ferroptosis. Eur J Pharmacol. 2024;966:176341.","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"2614_CR172","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.4103\/1673-5374.390960","volume":"19","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhou W, Zhang Z, Zhang L, Li M. Metformin alleviates spinal cord injury by inhibiting nerve cell ferroptosis through upregulation of heme oxygenase-1 expression. Neural Regeneration Res. 2024;19(9):2041\u20139.","journal-title":"Neural Regeneration Res"},{"issue":"1","key":"2614_CR173","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1186\/s12967-024-05436-9","volume":"22","author":"C Xing","year":"2024","unstructured":"Xing C, Liu S, Wang L, Ma H, Zhou M, Zhong H, Zhu S, Wu Q, Ning G. Metformin enhances endogenous neural stem cells proliferation, neuronal differentiation, and inhibits ferroptosis through activating AMPK pathway after spinal cord injury. J Translational Med. 2024;22(1):723.","journal-title":"J Translational Med"},{"key":"2614_CR174","doi-asserted-by":"crossref","unstructured":"Xu L, Li W, Chen Y, Liu S, Liu G, Luo W, Cao G, Wang S. Metformin Regulates Cardiac Ferroptosis to Reduce Metabolic Syndrome-Induced Cardiac Dysfunction. Applied biochemistry and biotechnology 2024.","DOI":"10.1007\/s12010-024-05038-7"},{"key":"2614_CR175","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.freeradbiomed.2021.01.033","volume":"165","author":"WQ Ma","year":"2021","unstructured":"Ma WQ, Sun XJ, Zhu Y, Liu NF. Metformin attenuates hyperlipidaemia-associated vascular calcification through anti-ferroptotic effects. Free Radic Biol Med. 2021;165:229\u201342.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2614_CR176","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1080\/13880209.2023.2212700","volume":"61","author":"Z Wu","year":"2023","unstructured":"Wu Z, Bai Y, Qi Y, Chang C, Jiao Y, Bai Y, Guo Z. Metformin ameliorates ferroptosis in cardiac ischemia and reperfusion by reducing NOX4 expression via promoting AMPK\u03b1. Pharm Biol. 2023;61(1):886\u201396.","journal-title":"Pharm Biol"},{"key":"2614_CR177","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.freeradbiomed.2023.06.004","volume":"205","author":"HH Liao","year":"2023","unstructured":"Liao HH, Ding W, Zhang N, Zhou ZY, Ling Z, Li WJ, Chen S, Tang QZ. Activation of AMPK\u03b12 attenuated doxorubicin-induced cardiotoxicity via inhibiting lipid peroxidation associated ferroptosis. Free Radic Biol Med. 2023;205:275\u201390.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2614_CR178","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/13880209.2023.2225543","volume":"61","author":"J Rong","year":"2023","unstructured":"Rong J, Li C, Zhang Q, Zheng G, Fan W, Pan Z, Shi S. Hydroxysafflor yellow A inhibits endothelial cell ferroptosis in diabetic atherosclerosis mice by regulating miR-429\/SLC7A11. Pharm Biol. 2023;61(1):404\u201315.","journal-title":"Pharm Biol"},{"key":"2614_CR179","doi-asserted-by":"publisher","first-page":"112852","DOI":"10.1016\/j.intimp.2024.112852","volume":"140","author":"C Yang","year":"2024","unstructured":"Yang C, Guo W, He R, Meng X, Fu J, Lu Y. Dietary capsaicin attenuates cardiac injury after myocardial infarction in type 2 diabetic mice by inhibiting ferroptosis through activation of TRPV1 and Nrf2\/HMOX1 pathway. Int Immunopharmacol. 2024;140:112852.","journal-title":"Int Immunopharmacol"},{"key":"2614_CR180","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.bbrc.2021.07.090","volume":"572","author":"H Kitakata","year":"2021","unstructured":"Kitakata H, Endo J, Hashimoto S, Mizuno E, Moriyama H, Shirakawa K, Goto S, Katsumata Y, Fukuda K, Sano M. Imeglimin prevents heart failure with preserved ejection fraction by recovering the impaired unfolded protein response in mice subjected to cardiometabolic stress. Biochem Biophys Res Commun. 2021;572:185\u201390.","journal-title":"Biochem Biophys Res Commun"},{"key":"2614_CR181","doi-asserted-by":"crossref","unstructured":"Zhou J, Xia W, Chen J, Han K, Jiang Y, Zhang A, Zhou D, Liu D, Lin J, Cai Y et al. Propofol and salvianolic acid a synergistically attenuated cardiac ischemia\u2013reperfusion injury in diabetic mice via modulating the CD36\/AMPK pathway. Burns Trauma 2024, 12.","DOI":"10.1093\/burnst\/tkad055"},{"key":"2614_CR182","doi-asserted-by":"crossref","unstructured":"Wang M, Tang J, Zhang S, Pang K, Zhao Y, Liu N, Huang J, Kang J, Dong S, Li H et al. Exogenous H2S initiating Nrf2\/GPx4\/GSH pathway through promoting Syvn1-Keap1 interaction in diabetic hearts. Cell Death Discovery 2023, 9(1).","DOI":"10.1038\/s41420-023-01690-w"},{"issue":"7","key":"2614_CR183","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1002\/ptr.7798","volume":"37","author":"X Li","year":"2023","unstructured":"Li X, Li Z, Dong X, Wu Y, Li B, Kuang B, Chen G, Zhang L. Astragaloside IV attenuates myocardial dysfunction in diabetic cardiomyopathy rats through downregulation of CD36-mediated ferroptosis. Phytother Res. 2023;37(7):3042\u201356.","journal-title":"Phytother Res"},{"issue":"3","key":"2614_CR184","doi-asserted-by":"publisher","first-page":"C724","DOI":"10.1152\/ajpcell.00565.2023","volume":"326","author":"H Wu","year":"2024","unstructured":"Wu H, Zhang P, Zhou J, Hu S, Hao J, Zhong Z, Yu H, Yang J, Chi J, Guo H. Paeoniflorin confers ferroptosis resistance by regulating the gut microbiota and its metabolites in diabetic cardiomyopathy. Am J Physiol Cell Physiol. 2024;326(3):C724\u201341.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2614_CR185","doi-asserted-by":"crossref","unstructured":"Zhang P, Wu H, Lou H, Zhou J, Hao J, Lin H, Hu S, Zhong Z, Yang J, Guo H, et al. Baicalin attenuates Diabetic Cardiomyopathy in vivo and in Vitro by inhibiting autophagy and cell death through SENP1\/SIRT3 signaling pathway activation. Antioxidants & redox signaling; 2024.","DOI":"10.1089\/ars.2023.0457"},{"issue":"2suppl","key":"2614_CR186","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2047487319878371","volume":"26","author":"E Dal Canto","year":"2019","unstructured":"Dal Canto E, Ceriello A, Ryd\u00e9n L, Ferrini M, Hansen TB, Schnell O, Standl E, Beulens JW. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019;26(2suppl):25\u201332.","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"2614_CR187","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2020","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2020;31(2):107\u201325.","journal-title":"Cell Res"},{"issue":"4","key":"2614_CR188","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chembiol.2020.03.011","volume":"27","author":"A Anandhan","year":"2020","unstructured":"Anandhan A, Dodson M, Schmidlin CJ, Liu P, Zhang DD. Breakdown of an Ironclad Defense System: the critical role of NRF2 in mediating ferroptosis. Cell Chem Biology. 2020;27(4):436\u201347.","journal-title":"Cell Chem Biology"},{"key":"2614_CR189","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.yjmcc.2020.10.010","volume":"150","author":"N Wang","year":"2021","unstructured":"Wang N, Ma H, Li J, Meng C, Zou J, Wang H, Liu K, Liu M, Xiao X, Zhang H, et al. HSF1 functions as a key defender against palmitic acid-induced ferroptosis in cardiomyocytes. J Mol Cell Cardiol. 2021;150:65\u201376.","journal-title":"J Mol Cell Cardiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02614-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02614-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02614-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T08:52:46Z","timestamp":1738918366000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02614-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":189,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2614"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02614-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}